OIG Reports Medicare Part B Overpaid $35.8 Million for Outpatient Drugs

(By – King & Spalding, via www.jdsupra.com)

According to a recent report by the HHS Office of Inspector General (OIG), Medicare contractors in 13 jurisdictions overpaid providers by $35.8 million for select outpatient drugs, including injectable drugs used for cancer treatment and pain management, between July 1, 2009 and June 30, 2012.  The results are from the OIG’s performance of 13 individual reviews of payments for these select outpatient drugs, for which it issued 13 separate reports between January and July 2014.  As of May 4, 2015, Medicare contractors have recovered 63 percent of the $35.8 million in overpayments, and 10 of the 13 contractors have used the results of the OIG’s audits to provide ongoing provider education. Read more…

Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.